LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
  • AstraZeneca PLC (LSE: AZN) Latest News

    Investing Articles

    3 Stocks For A FTSE 100 Storm: British American Tobacco Plc, AstraZeneca plc & Reckitt Benckiser Group Plc

    Weather market turbulence with British American Tobacco Plc (LON:BATS), AstraZeneca plc (LON:AZN) and Reckitt Benckiser Group Plc (LON:RB).

    Read more »

    Investing Articles

    Is AstraZeneca plc Overvalued?

    AstraZeneca plc (LON: AZN) is one of the most expensive stocks around but is it worth it.

    Read more »

    Investing Articles

    3 Fast-Growing Pharmaceuticals Set To Outperform: Shire PLC, BTG plc and Dechra Pharmaceuticals plc

    Shire PLC (LON:SHP), BTG plc (LON:BTG) and Dechra Pharmaceuticals plc (LON:DPH) could boost your 2015 returns

    Read more »

    Investing Articles

    5 Stunning Pharma Stocks: GlaxoSmithKline plc, AstraZeneca plc, Shire PLC, BTG plc & Hikma Pharmaceuticals Plc

    These 5 pharma stocks could be worth buying right now: GlaxoSmithKline plc (LON:GSK), AstraZeneca plc (LON:AZN), Shire PLC (LON:SHP), BTG…

    Read more »

    Investing Articles

    Will Shire PLC Acquisition Help It Beat GlaxoSmithKline plc And AstraZeneca plc?

    Is Shire PLC (LON: SHP) setting its sights on GlaxoSmithKline plc (LON: GSK) and AstraZeneca plc (LON: AZN)?

    Read more »

    Investing Articles

    AstraZeneca plc, GlaxoSmithKline plc And Shire PLC Are Set For A Decade Of Rapid Growth

    AstraZeneca plc (LON: AZN), GlaxoSmithKline plc (LON: GSK) and Shire PLC (LON: SHP) are set for rapid growth as sales explode.

    Read more »

    Investing Articles

    Will Hikma Pharmaceuticals Plc Beat GlaxoSmithKline plc And AstraZeneca plc Again In 2015?

    While GlaxoSmithKline plc (LON: GSK) and AstraZeneca plc (LON: ASN) have had a tough time, Hikma Pharmaceuticals Plc (LON: HIK)…

    Read more »

    Investing Articles

    Why I Think Shire plc Will Outperform AstraZeneca plc And GlaxoSmithKline plc By At Least 10% In 2015

    Alessandro Pasetti explains why Shire plc (LON:SHP) is his favourite pick, followed by GlaxoSmithKline plc (LON:GSK), and why he'd avoid…

    Read more »

    Investing Articles

    How GlaxoSmithKline PLC And AstraZeneca PLC Will Fare In 2015

    Are GlaxoSmithKline plc (LON: GSK) and AstraZeneca plc (LON: AZN) buys in 2015?

    Read more »

    Investing Articles

    Will Dividends At AstraZeneca plc Really Outstrip The Market In 2015?

    Royston Wild explains why AstraZeneca plc (LON: AZN) could be considered a perilous dividend pick.

    Read more »

    Investing Articles

    How Will GlaxoSmithKline plc, AstraZeneca plc And Shire PLC Fare During 2015?

    After the collapse of supermarket shares, will GlaxoSmithKline plc (LON: GSK), AstraZeneca plc (LON: AZN) and Shire plc (LON: SHP)…

    Read more »

    Investing Articles

    Will Crowd Sourcing Help AstraZeneca plc And GlaxoSmithKline plc Rekindle Growth?

     AstraZeneca plc (LON:AZN) and GlaxoSmithKline plc (LON: GSK) are pooling their resources to try and restart growth.

    Read more »